gemcitabine has been researched along with Pancreatic Fistula in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Sasaki, H; Sudo, T; Sueda, T; Uemura, K | 1 |
| Albarello, L; Balzano, G; Braga, M; Capretti, G; Castoldi, R; Cereda, S; Di Carlo, V; Doglioni, C; Pecorelli, N; Reni, M | 1 |
2 other study(ies) available for gemcitabine and Pancreatic Fistula
| Article | Year |
|---|---|
Is pancreatic fistula associated with worse overall survival in patients with pancreatic carcinoma?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Oxonic Acid; Pancreatectomy; Pancreatic Fistula; Pancreatic Neoplasms; Severity of Illness Index; Survival Rate; Tegafur | 2015 |
Preoperative chemotherapy does not adversely affect pancreatic structure and short-term outcome after pancreatectomy.
Topics: Adenocarcinoma; Adipose Tissue; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fibrosis; Gemcitabine; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Pancreatectomy; Pancreatic Fistula; Pancreatic Neoplasms; Pancreaticoduodenectomy; Postoperative Hemorrhage; Time Factors; Treatment Outcome | 2013 |